drugset / Trial / NCT04531332
Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigator's goal in this study is to determine the clinical efficacy and safety of continuous infusion in comparison with standard intermittent infusion.
Timeline
- Start
- 2019-11-15
- Primary completion
- 2021-09-15
- Completion
- 2021-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linezolid | Other / unclassified | 600 mg | Intravenous |
| Subject | Linezolid | Other / unclassified | 1200 mg | Intravenous |